Paula Mariana Kustiawan

Dr. Paula Mariana Kustiawan

Pharmacy, Universitas Muhammadiyah Kalimantan Timur, Samarinda, Kalimantan Timur, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2017 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
Paula Mariana KustiawanPaula Mariana Kustiawan
Paula Mariana Kustiawan
KLKriengsak Lirdprapamongkol
Kriengsak Lirdprapamongkol
TPTanapat Palaga
Tanapat Palaga
SPSongchan Puthong
Songchan Puthong
PPPreecha Phuwapraisirisan
Preecha Phuwapraisirisan
CCChanpen Chanchao
Chanpen Chanchao
Cardol is a major bioactive constituent in the Trigona incisa propolis from Indonesia, with a strong in vitro antiproliferative activity against the SW620 colorectal adenocarcinoma cell line (IC50 of 4.51 ± 0.76 μg/mL). Cardol induced G0/G1 cell cycle arrest and apoptotic cell death. The present study was designed to reveal the mechanism of cardol’s antiproliferative effect and induction of apoptosis. Changes in cell morphology were observed by light microscopy. To determine whether the mitochondrial apoptotic pathway was involved in cell death, caspase-3 and caspase-9 activities, western blot analysis, mitochondrial membrane potential, and intracellular reactive oxygen species (ROS) levels were assayed. Changes in the cell morphology and the significantly increased caspase-3 and caspase-9 activities, plus the cleavage of pro-caspase-3, pro-caspase-9 and PARP, supported that cardol caused apoptosis in SW620 cells within 2 h after treatment by cardol. In addition, cardol decreased the mitochondrial membrane potential while increasing the intracellular ROS levels in a time- and dose-dependent manner. Antioxidant treatment supported that the cardol-induced cell death was dependent on ROS production. Cardol induced cell death in SW620 cells was mediated by oxidative stress elevation and the mitochondrial apoptotic pathway, and these could be the potential molecular mechanism for the antiproliferative effect of cardol.

26 January 2024 in ADMET and DMPK
Verified
Journal Article
Open access
PDF file
Paula Mariana KustiawanPaula Mariana Kustiawan
Paula Mariana Kustiawan
PSPutri Hawa Syaifie
Putri Hawa Syaifie
KSKhalish Arsy Al Khairy Siregar
Khalish Arsy Al Khairy Siregar
DIDelfritama Ibadillah
Delfritama Ibadillah
EMEtik Mardliyati
Etik Mardliyati
Background and purpose: Scientific research is crucial to develop therapies for various disease severity levels, as modern drugs cause side effects and are difficult to predict. Researchers are exploring herbal alternatives with fewer side effects, particularly propolis, which has been validated through in vitro, in vivo, and clinical studies. This will focus on scientific evidence and its supporting technology for developing new bioactive compounds for chronic diseases. Nanotechnology can improve the delivery and absorption of herbal medicines, which often have poor bioavailability due to their high molecular weight and solubility in water, particularly in oral medicines. This technology can enhance propolis's effects through multi-target therapy and reduce side effects. Experimental approach: All publications related to each section of this review were discovered using the search engines Google Scholar, Scopus, and Pubmed. This was only available for publication between 2013 and 2023. The selected publications were used as references in this review after being thoroughly studied. Key results: Evaluation of propolis active compounds, the classification of propolis nano formulations, design concepts, and mechanisms of action of propolis nano formulation. Additionally, the challenges and prospects for how these insights can be translated into clinical benefits are discussed. Conclusion: In the last ten years, a list of nanoformulation propolis has been reported. This review concludes the difficulties encountered in developing large-scale nanoformulations. To commercialize them, improvements in nano carrier synthesis, standardized evaluation methodology within the framework of strategy process improvement, and Good Manufacturing Practices would be required.

1 January 2022 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
Paula Mariana KustiawanPaula Mariana Kustiawan
Paula Mariana Kustiawan
AAAbdul Aziz
Abdul Aziz
VYVeggy Nadia Yuliawan
Veggy Nadia Yuliawan
BACKGROUND: In the current pandemic era, people are trying to find additional income, such as stingless bee cultivation. Especially bee species of Heterotrigona itama, because the selling value of stingless bee honey for maintaining health is quite high. However, the potential of other bee products such as propolis is still underutilized. AIM: In this study, the antioxidant and antibacterial activity of propolis from various fractions were investigated. MATERIALS AND METHODS: H. itama propolis was extracted with 96% ethanol to obtain ethanol extract propolis (EEP). Then, it was used for liquid-liquid partition with different polarities (n-hexane and ethyl acetate) to obtain the n-hexane fraction (HF) and ethyl acetate fraction (EAF). These fractions were tested for antioxidants using the DPPH method and antibacterial against bacteria Propionibacterium acne, Staphylococcus aureus, and Escherichia coli using the agar well diffusion method. Vitamin C was used as a positive control in the antioxidant assay and Thiampenicol was used in the bacterial assay. RESULTS: The EAF had better antioxidant activity (IC50 128.46 ug/mL) than the ethanol extract (IC50 205.86 ug/mL) and n-HF (IC50 350.01 g/mL). Antibacterial activity of EEP at 200 ug/mL against P. acne was 6 ± 1.5 mm, which was categorized as medium inhibition, while the other fractions were classified as weak. CONCLUSION: EAF had the highest antioxidant activity, meanwhile EEP is the most potent on antibacterial activity. The results obtained are influenced by the environment, where the sample is taken, which is less varied in plant sources and the time of sample collection.

25 August 2021 in Journal of Fundamental and Applied Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
AAAbdul Aziz
Abdul Aziz
VYVeggy Nadya Yuliawan
Veggy Nadya Yuliawan
Paula Mariana KustiawanPaula Mariana Kustiawan
Paula Mariana Kustiawan
Propolis is one of the natural products produced by kelulut bees and is still not widely used. The type of stingless bee that is the prima donna in the community is Heterotrigona itama. This study aims to determine the phytochemical content of the n-hexane fraction of Heterotrigona itama bee propolis collected from Kutai Kartanegara, East Kalimantan. The n-hexane fraction was obtained from the methanol extract of H. itama propolis by the liquid-liquid partition method. After obtaining the n-hexane fraction, the research continued with a qualitative phytochemical test to identify the compound and determine total phenolic. Antibacterial activity was determined by the agar well diffusion method with a serial concentration in Escherichia coli bacteria. Qualitative phytochemical analysis in the form of color changes showed that the n-hexane fraction of H. itama propolis contained flavonoids, alkaloids, saponins, and tannins. Based on the results, the total phenolic content of the n-hexane fraction sample was 490 mgGAE/100 g. It caused the n-hexane fraction to have lower phenolic content than the methanol extract (792 mg GAE100 g). Furthermore, this result indicated that the non-polar fraction was not substantial enough to extracted phenolic compounds. It correlated to the antibacterial activity of the n-hexane fraction, which was very weak (2 mm ± 1.5) at 200µg/mL concentration.

19 October 2024 in Heliyon
Verified
Journal Article
Open access
Paula Mariana KustiawanPaula Mariana Kustiawan
Paula Mariana Kustiawan
KSKhalish Arsy Al Khairy Siregar
Khalish Arsy Al Khairy Siregar
MJMuhammad Miftah Jauhar
Muhammad Miftah Jauhar
DRDonny Ramadhan
Donny Ramadhan
EMEtik Mardliyati
Etik Mardliyati
PSPutri Hawa Syaifie
Putri Hawa Syaifie
Hepatocellular Carcinoma (HCC) is commonly treated with surgery, liver transplantation, and chemotherapy, but recurrence and metastasis remain challenges. Natural complementary therapies like propolis, known for its hepatoprotective properties, are gaining interest due to limited efficacy and toxicity of conventional chemotherapy. This study aims to identify core targets for HCC, assess the therapeutic potential of East Kalimantan propolis (EKP) from stingless bees, and analyze the molecular interactions. EKP compounds were analyzed using target prediction tools related to HCC, alongside clinical data from the Gene Expression Omnibus (GEO) database, to identify overlapping genes with clinical relevance. The selected genes were then subjected to protein-protein interaction (PPI), GO and KEGG enrichment, immunohistochemical comparison and survival analysis to identify potential core targets and related pathways for HCC therapy. Furthermore, molecular docking and dynamics were conducted to verify the molecular interactions and stability of EKP compounds with targets. 108 genes have been selected as HCC potential targets, which mostly associated with MicroRNAs in cancer, chemical carcinogenesis, and viral carcinogenesis pathways. These targets were obtained by overlapping genes from GEO clinical databases and target predictors. PPI network analysis revealed 4 main targets of propolis in HCC. Furthermore, differential expression genes, survival analysis, and Immunohistochemical analysis from databases suggested that AKR1C3 and MAPK1 promote HCC progression and shorten survival rate of HCC patients. Molecular docking and dynamic studies confirmed strong binding affinity and stability of Baicalein, Chrysin, Quercetin, and Myricetin with receptor targets within simulation time. This study provides insight into the mechanism of action of EKP on HCC and identifies AKR1C3 and MAPK1 as candidate target treatments for future drug development.

12 January 2024 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
KSKhalish Arsy Al Khairy Siregar
Khalish Arsy Al Khairy Siregar
PSPutri Hawa Syaifie
Putri Hawa Syaifie
MJMuhammad Miftah Jauhar
Muhammad Miftah Jauhar
AAAdzani Gaisani Arda
Adzani Gaisani Arda
NRNurul Taufiqu Rochman
Nurul Taufiqu Rochman
EMEtik Mardliyati
Etik Mardliyati
Cirrhosis naturally progresses through three stages: compensated, decompensated, and late decompensated, which carry an elevated risk of death. Although curcumin's anti-cirrhosis effects have been studied, underlying mechanism in preventing cirrhosis progression and the correlation between curcumin's action with upregulated genes remains insufficiently explored. In this study, we employed network pharmacology approach to construct a drug-target-disease network through bioinformatics and validate the findings with molecular docking and dynamic simulation. The curcumin-targeted liver cirrhosis network encompassed 54 nodes with 282 edges in protein-protein interactions (PPI) network. By utilizing network centrality analysis, we identified eight crucial genes. KEGG enrichment pathway revealed that these crucial genes are involved in pathway of cancer, endocrine resistance, estrogen signaling, chemical carcinogenesis-receptor activation, lipid metabolism, and atherosclerosis. Notably, these eight genes predominantly participate in cancer-related pathways. Further investigation revealed upregulation of four genes and downregulation of four others in hepatocellular carcinoma patients. These upregulated genes-MAPK8, SRC, PPARG, and HSP90AA1-strongly correlated with reduced survival probability in liver hepatocellular carcinoma patients with survival times approximately under 4000 days (∼11 years). Molecular docking and molecular dynamic results exhibited curcumin's superior binding affinities and stability compared to native ligands of MAPK8, SRC, PPARG, and HSP90AA1 within 50 ns simulations. Moreover, MM-GBSA analysis showed stronger binding energy of curcumin to MAPK8, SRC, and HSP90AA1 than native ligand. In conclusion, this study provides valuable insights into curcumin's potential mechanisms in preventing liver cirrhosis progression, specifically in HCC. These findings offer a theoretical basis for further pharmacological research into anti-HCC effect of curcumin.Communicated by Ramaswamy H. Sarma.